Recall of Dr. King's SafeCare Rx Insecurity due to microbial contamination
The FDA is recalling Dr. King's SafeCare Rx Insecurity because of microbial contamination found in the product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class I according to the source metadata, which mandates a minimum severity score of 4 per the rubric. Additionally, the recall reason involves microbial contamination—a serious health hazard—further supporting a high severity rating.
Plain-English summary
The U.S. Food and Drug Administration is recalling Dr. King's SafeCare Rx Insecurity, a 2 fl. oz. prescription medication produced by King Bio Inc., due to the discovery of microbial contamination. This recall affects specific lots (042116A and 072216N) with expiration dates of April 19 and July 19, 2019, distributed across the United States, Canada, and Australia. Consumers are strongly advised to discontinue use of this product immediately and contact their healthcare provider for guidance. The recall is classified as FDA Class I, indicating a serious safety concern that requires prompt consumer action.
Microbial contamination represents a direct health risk as it can lead to infection or adverse reactions depending on the nature of the contaminant. Because the product is a prescription medication and the agency has designated this as a Class I recall, the situation warrants a higher severity rating. The presence of microbial contamination in a drug product falls under the rubric's requirement for at least a severity score of 4 when combined with a Class I classification.
Consumers should not consume the recalled product and should seek medical attention if they experience any symptoms following exposure. The recall covers multiple lots with different expiration dates, and the manufacturer King Bio Inc. is responsible for issuing corrective actions such as product replacement or refund. All affected consumers are urged to follow the FDA's recommendations and report any adverse events to local health authorities.
The recalled product
- Product
- Dr. King's SafeCare Rx Insecurity, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955256021, NDC 57955-2561-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — prescription medication
- Hazard
- Affected units
- 70
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 042116A Exp. 04/19
- 072216N Exp. 07/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15